Eden Research PLC (EDEN)

Industry Agricultural Inputs

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

2.80p

Buy

2.90p

arrow-down-0.05p (-1.72%)

Prices updated at 02 Apr 2026, 15:43 BST

Prices minimum 15 mins delay

Prices in GBX

Eden Research PLC is a UK based company engaged in the development and marketing of intellectual property, particularly in terpenes and other health related projects. It operates through Biocides and Human health, Animal health and Agrochemical segments.

FTSE All-Share

0.59%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Basic Materials

Industry

Agricultural Inputs

Chairman

Mr. Lykele van der Broek

CEO

Mr. Sean Michael Smith

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

23

Head office

67C Innovation Drive

Abingdon

United Kingdom

OX14 4RQ

+44 1285359555

info@edenresearch.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Lykele van der Broek Non-Executive Director, Chairman	-
Mr. Robin James Scott Cridland Non-Executive Director	-
Mr. Derek Ian McAllan Non-Executive Director	-
Mr. Alexander John Abrey Executive Director, Chief Financial Officer and Company Secretary	-
Mr. Sean Michael Smith Executive Director, Chief Executive Officer	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Unicorn Asset Management Ltd	31,826,923
Unicorn AIM VCT Series 3 ORD	31,826,923
Hargreave Hale Limited	24,785,840
Octopus Investments Limited	16,405,063
Maven Capital Partners UK LLP	5,995,108

Director dealings

Date chevron-l-regular chevron-r-regular	Action
17 Sep 2025	Purchase
17 Sep 2025	Purchase

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.